Wednesday, June 23, 2010 9:51:03 AM
Next-Generation Heat Mirror® Suspended Film and Multi-Cavity Insulating Glass Technology to Help Commercialize R-10 Windows
Press Release Source: Southwall Technologies Inc. On Wednesday June 23, 2010, 9:20 am
PALO ALTO, Calif.--(BUSINESS WIRE)--Southwall Technologies Inc., (OTCBB:SWTX - News), the worldwide innovator of high performance, energy-saving films and glass products, has been awarded a $1.43 million stimulus grant from the US Department of Energy (DOE) to develop advanced technologies aimed at making homes and buildings more energy efficient. Southwall will use the funding to accelerate development of higher performance and lower cost Heat Mirror low-emissivity and solar-reflective films and multi-cavity, suspended-film insulating glass technology to enable the broad commercialization of “super-insulating” R-10 windows.
According to DOE, the nation’s 114 million homes and 74 million square feet of commercial floor space account for 40 percent of US total energy consumption and 39 percent of total carbon dioxide emissions. Because windows are the energy-efficiency weak link in homes and buildings, DOE is focusing grant funding on the development of innovative technologies that can create energy-saving windows that insulate like walls.
“The designation of Southwall as a DOE grant recipient recognizes our leadership in developing lightweight, multi-cavity insulating glass technology that promises to drive the performance of a new generation of cost-effective and energy-efficient windows,” said Dennis Capovilla, Southwall chief executive officer. “We are pleased that DOE is working closely with industry to accelerate disruptive technology innovation that can dramatically reduce our nation’s energy use.”
Southwall is one of seven California-based companies, including National Semiconductor and Applied Materials, to receive a coveted DOE grant for advanced energy-efficient building technology projects.
About Heat Mirror Suspended Film Technology
Heat Mirror insulating glass is a superior multi-cavity solution that suspends one or more low-emissivity and solar-reflective Heat Mirror films inside of an insulating glass unit to create two, three or even four insulating cavities without adding weight. This innovative approach enables window fabricators to offer higher performance glass options for their existing window systems today as well as for next-generation window systems in development. Heat Mirror suspended film technology combines the best of film-based and glass-based technologies to create the industry's first "super glass" that enables a new generation of cost-effective R-10 windows. Southwall's Heat Mirror® suspended-film insulating glass has been selected to be retrofitted into all 6,500 windows in New York’s Empire State Building as a leading component of a major energy efficiency upgrade.
About Southwall Technologies
Southwall Technologies Inc. is recognized as a leader in the development and manufacture of high performance, energy-saving films and glass products that dramatically improve the energy efficiency of residential, commercial and automotive glass. Southwall is an ISO 9001:2000-certified manufacturer with customers in over 25 countries.
Photos/Multimedia Gallery Available: http://www.businesswire.com/cgi-bin/mmg.cgi?eid=6337895&lang=en
Recent SWTX News
- Form 8-K - Current report • Edgar (US Regulatory) • 05/17/2024 08:53:56 PM
- SpringWorks Therapeutics to Participate in the BofA Securities 2024 Health Care Conference • GlobeNewswire Inc. • 05/08/2024 11:00:27 AM
- SpringWorks Therapeutics Reports First Quarter 2024 Financial Results and Highlights Recent Business Updates • GlobeNewswire Inc. • 05/02/2024 10:30:00 AM
- SpringWorks Therapeutics Announces Abstracts Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting • GlobeNewswire Inc. • 04/24/2024 05:31:32 PM
- SpringWorks Therapeutics to Report First Quarter 2024 Financial Results Thursday, May 2, 2024 • GlobeNewswire Inc. • 04/18/2024 11:00:28 AM
- SpringWorks Therapeutics Initiates Rolling Submission of New Drug Application to the FDA for Mirdametinib for the Treatment of Children and Adults with NF1-PN • GlobeNewswire Inc. • 03/04/2024 11:30:11 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/01/2024 10:16:11 PM
- SpringWorks Therapeutics Announces European Medicines Agency Validation for Marketing Authorization Application of Nirogacestat for the Treatment of Adults with Desmoid Tumors • GlobeNewswire Inc. • 02/29/2024 01:30:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/27/2024 01:28:17 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 02/27/2024 01:23:12 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 02/27/2024 12:29:18 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/27/2024 11:51:44 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/27/2024 11:44:27 AM
- SpringWorks Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Business Updates • GlobeNewswire Inc. • 02/27/2024 11:30:00 AM
- SpringWorks Therapeutics to Present at Upcoming Investor Conferences • GlobeNewswire Inc. • 02/22/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/20/2024 11:56:43 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/16/2024 06:09:51 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 01:56:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/06/2024 02:24:32 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/06/2024 02:23:02 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/02/2024 09:38:01 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/02/2024 09:01:27 PM
- SpringWorks Therapeutics to Participate in the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference • GlobeNewswire Inc. • 01/31/2024 12:00:50 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/09/2024 02:13:06 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/09/2024 02:12:02 AM
Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology • AVAI • May 23, 2024 8:00 AM
Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM